Hemodynamic Changes During Operative Hysteroscopy
Кључне речи
Апстрактан
Опис
Operative hysteroscopy has become a standard surgical treatment for abnormal uterine bleeding unresponsive to conservative medical management since it was shown as a safe and effective alternative to hysterectomy.(2,3) Monopolar resectoscope necessitates an irrigating fluid that should be a non-conductive and salt free solution such as glycine 1.5% or sorbitol 3%.(4) Physiologic irrigating fluids (e.g. saline 0.9%) are contraindicated with these instruments since electric current generated by any monopolar electro surgical unit is preferentially conducted through low impedance fluid rather than through tissue and consequently it's difficult to initiate cutting and impossible to create significant tissue coagulation with these devices The clinical drawback of non-conductive irrigating solution (e.g. glycine 1.5%) is the risk of excessive fluid absorption leading to symptomatic dilutional hyponatremia and for hypotonic solutions, hypo-osmolarity and secondary cerebral oedema as Glycine is metabolized to carbon dioxide, water and ammonia, and may lead to intra-cellular over hydration and neurotoxicity which is clinically reflected as hypoxemia, agitation, nausea and hypertension.(5).Although rare, irreversible neurologic damage and death have been reported after excessive absorption of salt free irrigating solutions during routine operative hysteroscopy(6)Theoretically, distension with 0.9% saline as a distension medium avoids most of the above mentioned risks associated with hyper absorption of non electrolytic distension media(7) However, there is no doubt that excessive absorption of normal saline can be fatal(8).
Recently , it has been suggested that the type of anesthesia could modify fluid absorption(9). General anaesthesia has been associated with less Glycine absorption than epidural anaesthesia: the latter being associated with systemic vasodilatation(9).
Датуми
Последња верификација: | 04/30/2017 |
Фирст Субмиттед: | 05/12/2017 |
Предвиђена пријава послата: | 05/22/2017 |
Прво објављено: | 05/24/2017 |
Послато последње ажурирање: | 05/22/2017 |
Последње ажурирање објављено: | 05/24/2017 |
Стварни датум почетка студије: | 07/04/2017 |
Процењени датум примарног завршетка: | 09/16/2018 |
Предвиђени датум завршетка студије: | 09/16/2018 |
Стање или болест
Интервенција / лечење
Drug: normal saline0.9%
Drug: 1.5% GLYCINE
Фаза
Групе руку
Арм | Интервенција / лечење |
---|---|
Active Comparator: normal saline0.9% 0.9% saline distension media is used as long as diathermy is not in use | Drug: normal saline0.9% 0.9% saline as distension medium as long as diathermy is not in use |
Placebo Comparator: 1.5% GLYCINE 1.5% GLYCINE DURING OPERATIVE HYSTEROSCOPY as long as diathermy is in use | Drug: 1.5% GLYCINE 1.5% Glycine alone during hysteroscopy as long as diathermy is in use |
Критеријуми
Узраст подобан за студирање | 20 Years До 20 Years |
Полови подобни за студирање | Female |
Прихвата здраве волонтере | да |
Критеријуми | Inclusion Criteria: - In this study we will include 60 patients (age ranged from 20 to 40 years) with uterine size less than 12 weeks and cavity depth less than 12cm. Different types of intrauterine lesions (submucous fibroids of types 0, 1 and 2 with diameter less than 4 cm, polyps,septum and adhesions). Exclusion Criteria: - Any case with the following diseases will be excluded from the study. - Cardiac diseases (myocardial ischemia, myocardial infarction or valve lesions). - Renal impairment. - Neurological affection. - Chest diseases. - Hepatic impairment. - coagulation abnormalities. - Patient refusal. |
Исход
Примарне мере исхода
1. Change from Baseline Systolic Blood Pressure [data will be collected over 24 hours from the beginning of the procedure]